Clinical Trial Update: Evaluation of Treatment of High riSk proLiferative Diabetic retinopathY With Intravitreal Aflibercept injectioN [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intravitreal aflibercept injections for high-risk proliferative diabetic retinopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Diabetic Retinopathy

Drugs mentioned

• Aflibercept (Aflibercept)

Snippet

Sponsor: Valley Retina Institute | Conditions: Proliferative Diabetic Retinopathy | Phase 2 | Status: UNKNOWN